GERN

Geron Corporation

4.68 USD
+0.01 (+0.11%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Geron Corporation stock is up 25.34% since 30 days ago. The next earnings date is Aug 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 27 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 6 CALLs, 4 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
10 Jun 15:04 20 Sep, 2024 4.00 CALL 300 2084
10 Jun 18:41 19 Jul, 2024 6.00 CALL 1000 836
10 Jun 19:56 20 Sep, 2024 2.00 CALL 200 1948
11 Jun 15:07 17 Jan, 2025 5.00 PUT 249 616
11 Jun 15:10 17 Jan, 2025 5.00 PUT 1000 616
11 Jun 16:41 17 Jan, 2025 4.00 CALL 150 11416
11 Jun 18:45 19 Jul, 2024 5.00 PUT 947 12
13 Jun 17:42 20 Dec, 2024 3.50 PUT 3000 3
17 Jun 15:01 20 Dec, 2024 4.50 CALL 300 498
17 Jun 17:49 17 Jan, 2025 3.00 CALL 150 7634

About Geron Corporation

Geron Corporation focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials. The company was incorporated in 1990 and is headquartered in Foster City, California.

  • Barclays
    Tue Jun 11, 09:25
    buy
    initial
  • Barclays
    Mon Jun 10, 10:20
    buy
    initial
  • Stifel
    Mon Jun 10, 08:17
    buy
    confirm
  • Needham
    Fri Jun 7, 09:43
    buy
    confirm
  • Wedbush
    Fri Jun 7, 08:19
    buy
    confirm